Congress orders study on infant heart monitors to fight sudden death
H.R. 2168 — BO’s Act · Filed by Rudy Yakym (R-IN) · 13 cosponsors · Introduced Mar 14, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to study whether home cardiorespiratory monitors—devices that track an infant's heart rate and oxygen levels during sleep—can help prevent sudden unexpected infant death. Within one year, the Secretary must report to Congress on the monitors' effectiveness, accuracy, best practices for infant sleep environments, insurance coverage criteria, and whether they should be covered by public or private health plans.
Why we flagged it
The bill is a straightforward mandate for a government study on infant health technology. It creates no new programs, spending, or regulatory authority—only a fact-finding obligation to inform future policy on a public-health issue (sudden infant death prevention).
What the text implies
- Study findings may influence FDA regulatory classification of home cardiorespiratory monitors, potentially affecting market entry and approval timelines for new devices.
- Report recommendations on insurance coverage could create pressure on CMS and private insurers to expand reimbursement, shifting costs from families to payers.
The full analysis lists 3 implications of this text.
Who stands to gain
home cardiorespiratory monitor manufacturers; medical device companies; pediatric health technology vendors